Diabetes technology

Miniaturized Neural Networks for Deploying Fully Closed Loop Insulin Delivery Systems: A Pilot Study Featuring Flexible Meal Announcement Options

J Diabetes Sci TechnolPublished Randomised crossover trial

Authors' conclusion

This pilot-feasibility study demonstrates that the AIDANET system provides safe glycemic control. The small sample size (n = 6) limits overall generalizability, and further larger, statistically powered trials to validate these results are warranted.

Study context

Population
Adults with T1Dcrossover
Participants
6 adults
Comparison
AIDANET vs usual care
  • AIDANETn = 6
  • Usual caren = 6reference
Methodological detailspilot, free-living conditions
  • Pilot
  • Free-living conditions

Primary result

As reported in the abstract

Mean glucose · 7 days

Further findings

OutcomeAIDANETUsual care
TIR 70 to 180 mg/dL · 7 days66.4% ± 8.3%63.3% ± 14.9%

AIDANET hybrid bolusing options · 1 day each

Carbohydrate counting: Time-in-range (TIR)
57.1%
Carbohydrate counting: Time-below-range (TBR)
0.6%
Easy Bolus: TIR
70.5%
Easy Bolus: TBR
1.5%

Safety

OutcomeAIDANETUsual care
TBR <70 mg/dL · 7 daysRemained within acceptable margins1.6 ± 1.80.9 ± 1

Serious adverse events

Serious adverse events during the study
0

Original publication

Miniaturized Neural Networks for Deploying Fully Closed Loop Insulin Delivery Systems: A Pilot Study Featuring Flexible Meal Announcement Options. J Diabetes Sci Technol. Published 9 August 2025. doi:10.1177/19322968251364283

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.